1. 125 FEBRILE EPISODES IN PATIENTS WITH MDS TREATED WITH AZACITIDINE. A THREE YEAR MONOCENTRIC RETROSPECTIVE STUDY. Issue 1 (April 2015) Authors: Stamatoullas, A.; Rezine, I.; Menard, A.L.; Lanic, H.; David, M.; Daliphard, S.; Penther, D.; Cassuto, O.; Lenain, P.; Lepretre, S.; Contentin, N.; Lemasle, E.; Cardinael, N.; Fontura, M.L.; Fronville, C.; Jardin, F.; Bastard, C.; Tilly, H. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B‐CELL LYMPHOMA. (June 2017) Authors: Morschhauser, F.; Le Gouill, S.; Feugier, P.; Van Den Neste, E.; Nicolas‐Virelizier, E.; Bijou, F.; Salles, G.A.; Tilly, H.; Van Eygen, K.; Van Hoof, A.; Bonnet, C.; Haioun, C.; Bouabdallah, R.; Fabiani, B.; Xerri, L.; Cartron, G.; Houot, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL. (12th June 2019) Authors: Lemonnier, F.; Safar, V.; Ferchiou, A.; Cottereau, A.; Bachy, E.; Cartron, G.; Moles‐Moreau, M.; Delmer, A.; Bouabdallah, R.; Voillat, L.; Parrens, M.; Casasnovas, O.; Cacheux, V.; Réguy, C.; Tilly, H.; Meignan, M.; Gaulard, P.; de Leval, L.; Delfau‐Larrue, M.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL. (12th June 2019) Authors: Schmitz, N.F.; Dixon, J.G.; Salles, G.; Wall, A.; Cunningham, D.; Poeschel, V.; Haioun, C.; Tilly, H.; Ghesquieres, H.; Ziepert, M.; Flament, J.; Flowers, C.; Shi, Q.; Ruppert, A.S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL. (June 2017) Authors: Pettengell, R.; Uddin, R.; Boumendil, A.; Robinson, S.P.; Smith, G.; Hawkins, T.; Metzner, B.; Caballero, M.D.; Tilly, H.; Romejko‐Jarosinska, J.; Bence‐Bruckler, I.; To, B.; Niemann, C.; Kimby, E.; Dreger, P.; Schmitz, N.; Goldstone, A.H.; Montoto, S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL. (June 2017) Authors: Huet, S.; Szafer‐Glusman, E.; Xerri, L.; Bolen, C.; Punnoose, E.; Tonon, L.; Tilly, H.; Brice, P.; Feugier, P.; Tesson, B.; Viari, A.; Venstrom, J.M.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. GENE EXPRESSION PROFILING USING a RTMLPA ASSAY ALLOWS FOR AN ACCURATE CLASSIFICATION OF PERIPHERAL T‐CELL LYMPHOMA AND HIGHLIGHTS NOVEL SUBGROUPS WITHIN PTCLS‐NOS. (June 2017) Authors: Ruminy, P.; Drieux, F.; Abdel Sater, A.; Fataccioli, V.; Marchand, V.; Parrens, M.; Bossard, C.; Dobay, P.; Viailly, P.; Veresezan, L.; Dupuy, A.; Pujals, A.; Picquenot, J.; Tilly, H.; De Leval, L.; Jardin, F.; Gaulard, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY. (12th June 2019) Authors: Cottereau, A.; Vercellino, L.; Casasnovas, O.; Tilly, H.; Feugier, P.; Fruchart, C.; Roulin, L.; Oberic, L.; Pica, G.; Ribrag, V.; Abraham, J.; Simon, M.; Gonzalez, H.; Bouabdallah, R.; Fitoussi, O.; Sebban, C.; Lopez, A.; Macro, M.; Sahnes, L.; Morschhauser, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY. (June 2017) Authors: Bonnet, C.M.; Lamy, T.; Fruchart, C.; Legouill, S.; Gunzer, K.; Gastinne, T.; Jardin, F.; Karlin, L.; Houot, R.; Dupuis, J.; Tilly, H.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of Cytogenetics on Outcome after Allogeneic Transplantation for Myelodysplastic Syndrome or Post MDS Secundary Myeloid Leukemia. (April 2017) Authors: Menard, A.L.; Marcq, B.; Stamatoullas, A.; Contentin, N.; Lebreton, P.; Rezine, I.; Penther, D.; Etancelin, P.; Lepretre, S.; Lenain, P.; Lanic, H.; Lemasle, E.; Bastard, C.; Tilly, H.; Jardin, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗